An outbreak of Burkholderia cepacia associated with contamination of albuterol and nasal spray

Chest

Volumn 130, Issue 5, 2006, Pages 1346-1353

  Estivariz, Concepcion F ^b   Bhatti, Lubna I ^b   Pati, Ritu ^a   Jensen, Bette ^a   Arduino, Matthew J ^a   Jernigan, Daniel ^a   LiPuma, John J ^c   Srinivasan, Arjun ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Critical care; Health care associated pneumonia; Ventilation

Indexed keywords

COTRIMOXAZOLE; LEVOFLOXACIN; PIPERACILLIN; SALBUTAMOL;

ADULT; AEROSOL; AGED; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ASEPSIS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA COMPLEX; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG CONTAMINATION; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INSTRUMENT STERILIZATION; INTENSIVE CARE; MALE; NEBULIZATION; NEBULIZER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SAMPLING; SPUTUM CULTURE; VENTILATOR;

EID: 33751248260     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.5.1346     Document Type: Article

References (33)

1. Coenye T, LiPuma JJ. Molecular epidemiology of Burkholderia species. Front Biosci 2003; 8:55-67
2. Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria. Clin Infect Dis 1998; 27:S93-S99
3. Mortensen JE, Fisher MC, LiPuma JJ. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol 1995; 16:30-32
4. Oie S, Kamiya A. Microbial contamination of antiseptics and disinfectants. Am J Infect Control 1996; 24:389-395
5. Saiman L, Siegel J. Cystic Fibrosis Foundation Consensus Conference on Infection Control P. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am J Infect Control 2003; 31:S1-S62
6. Marione WJ, Tablan OC, Jarvis WR. The epidemiology of nosocomial epidemic Pseudomonas cepacia infections. Eur J Epidemiol 1987; 3:222-232
7. Takigawa K, Fujita J, Negayama K, et al. Nosocomial outbreak of Pseudomonas cepacia respiratory infection in immunocompromised patients associated with contaminated nebulizer devices. Kansenshogaku Zasshi 1993; 67:1115-1125
8. Jarvis WR, Olson D, Tablan O, et al. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol 1987; 3:233-236
9. Maningo E, Watanakunakorn C. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect 1995; 31:89-92
10. Centers for Disease Control and Prevention. Nosocomial Burkholderia cepacia infection and colonization associated with intrinsically contaminated mouthwash-Arizona, 1998. MMWR Morb Mortal Wkly Rep 1998; 47:926-928
11. Berthelot P, Grattard F, Mahul P, et al. Ventilator temperature sensors: an unusual source of Pseudomonas cepacia in nosocomial infection. J Hosp Infect 1993; 25:33-43
12. Burdge DR, NaMelna EM, Noble MA. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol 1993; 14:127-130
13. Hamill RJ, Houston ED, Georghiou PR, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995; 122:762-766
14. Loukil C, Saizou C, Doit C, et al. Epidemiologic investigation of Burkholderia cepacia acquisition in two pediatric intensive care units. Infect Control Hosp Epidemiol 2003; 24:707-710
15. Pegues CF, Pegues DA, Ford DS, et al. Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak. Epidemiol Infect 1996; 116:309-317
16. Ramsey AH, Skonieczny P, Coolidge DT, et al. Burkholderia cepacia lower respiratory tract infection associated with exposure to a respiratory therapist. Infect Control Hosp Epidemiol 2001; 22:423-426
17. Reboli AC, Koshinski R, Arias K, et al. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect Control Hosp Epidemiol 1996; 17:741-743
18. Weems JJ Jr. Nosocomial outbreak of Pseudomonas cepacia associated with contamination of reusable electronic ventilator temperature probes. Infect Control Hosp Epidemiol 1993; 14:583-586
19. Centers for Disease Control and Prevention. Manufacturer's recall of nasal spray contaminated with Burkholderia cepacia complex. MMWR Morb Mortal Wkly Rep 2004; 53:246
20. Dolan SA, Dowell E, LiPuma JJ, et al. An outbreak of Burkholderia cepacia complex associated with an intrinsically contaminated nasal decongestant spray [abstract A380]. Presented at the Eighteenth Annual North American Cystic Fibrosis Conference, St. Louis, MO, October 14-17, 2004
21. Standard methods for the analysis of water and wastewater. 20th ed. Washington, DC: American Public Health Association, 1998
22. Mahenthiralingam E, Bischof J, Byrne SK, et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000; 38:3165-3173
23. LiPuma JJ, Dulaney BJ, McMenamin JD, et al. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol 1999; 37:3167-3170
24. Maslow JN, Slutsky AM, Arbeit RD. Applications of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, et al, eds. Diagnostic molecular microbiology: principles and applications. Washington, DC: American Society for Microbiology, 1993; 563-572
25. Coenye T, Spilker T, Martin A, et al. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol 2002; 40:3300-3307
26. Horan TC, Emori TG. Definitions of key terms used in the NNIS System. Am J Infect Control 1997; 25:112-116
27. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13:606-608
28. Centers for Disease Control and Prevention, Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for preventing health-care-associated pneumonia, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:No RR03; 01
29. Craven DE, Lichtenberg DA, Goularte TA, et al. Contaminated medication nebulizers in mechanical ventilator circuits: source of bacterial aerosols. Am J Med 1984; 77:834-838
30. Centers for Disease Control and Prevention. Guideline for prevention of nosocomial pneumonia. Am J Infect Control 1994; 22:247-292
31. Magalhaes M, Doherty C, Govan JRW, et al. Polyclonal outbreak of Burkholderia cepacia complex bacteraemia in haemodialysis patients. J Hosp Infect 2003; 54:120-123
32. Agodi A, Barchitta M, Giannino V, et al. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages. J Hosp Infect 2002; 50:188-195
33. Coenye T, LiPuma JJ. Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes. Microbiology 2003; 149:77-88